INS and hyperlipidemia: In our study, with a mouse model exhibiting IR but no other T2DM features, which also had hyperlipidaemia due to a high-fat, high-cholesterol diet, DAPA treatment during the glucose challenge did not change glucose levels, despite increased insulin plasmatic concentration.